Absci Corporation (ABSI)
NASDAQ: ABSI · IEX Real-Time Price · USD
2.970
-0.040 (-1.33%)
At close: Jul 2, 2024, 4:00 PM
3.000
+0.030 (1.01%)
After-hours: Jul 2, 2024, 7:47 PM EDT
Absci Market Cap
Absci has a market cap or net worth of $335.86 million as of July 2, 2024. Its market cap has increased by 113.52% in one year.
Market Cap
335.86M
Enterprise Value
172.21M
1-Year Change
113.52%
Ranking
Category
Stock Price
$2.97
Market Cap Chart
Since the IPO on July 22, 2021, Absci's market cap has decreased from $1.45B to $335.86M, a decrease of -76.77%. That is a compound annual growth rate of -39.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 335.90M | -13.94% |
| Dec 29, 2023 | 390.30M | 101.19% |
| Dec 30, 2022 | 194.00M | -74.45% |
| Dec 31, 2021 | 759.30M | -47.49% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADC Therapeutics | 354.11M |
| Agenus | 350.48M |
| Jasper Therapeutics | 349.08M |
| Anavex Life Sciences | 347.88M |
| Scilex Holding Company | 340.64M |
| Verrica Pharmaceuticals | 337.24M |
| AxoGen | 336.96M |
| Kyverna Therapeutics | 336.73M |